title: Mechanisms of lung endothelial barrier disruption induced by cigarette smoke: role of oxidative stress and ceramides.
abstract: The epithelial and endothelial cells lining the alveolus form a barrier essential for the preservation of the lung respiratory function, which is, however, vulnerable to excessive oxidative, inflammatory, and apoptotic insults. Whereas profound breaches in this barrier function cause pulmonary edema, more subtle changes may contribute to inflammation. The mechanisms by which cigarette smoke (CS) exposure induce lung inflammation are not fully understood, but an early alteration in the epithelial barrier function has been documented. We sought to investigate the occurrence and mechanisms by which soluble components of mainstream CS disrupt the lung endothelial cell barrier function. Using cultured primary rat microvascular cell monolayers, we report that CS induces endothelial cell barrier disruption in a dose- and time-dependent manner of similar magnitude to that of the epithelial cell barrier. CS exposure triggered a mechanism of neutral sphingomyelinase-mediated ceramide upregulation and p38 MAPK and JNK activation that were oxidative stress dependent and that, along with Rho kinase activation, mediated the endothelial barrier dysfunction. The morphological changes in endothelial cell monolayers induced by CS included actin cytoskeletal rearrangement, junctional protein zonula occludens-1 loss, and intercellular gap formation, which were abolished by the glutathione modulator N-acetylcysteine and ameliorated by neutral sphingomyelinase inhibition. The direct application of ceramide recapitulated the effects of CS, by disrupting both endothelial and epithelial cells barrier, by a mechanism that was redox and apoptosis independent and required Rho kinase activation. Furthermore, ceramide induced dose-dependent alterations of alveolar microcirculatory barrier in vivo, measured by two-photon excitation microscopy in the intact rat. In conclusion, soluble components of CS have direct endothelial barrier-disruptive effects that could be ameliorated by glutathione modulators or by inhibitors of neutral sphingomyelinase, p38 MAPK, JNK, and Rho kinase. Amelioration of endothelial permeability may alleviate lung and systemic vascular dysfunction associated with smoking-related chronic obstructive lung diseases.
authors.affiliation: Department of Medicine, Indiana University School of Medicine, Indianapolis, 46202-5120, USA.
authors.forename: Kelly S
authors.initials: KS
authors.lastname: Schweitzer
authors.forename: Hadi
authors.initials: H
authors.lastname: Hatoum
authors.forename: Mary Beth
authors.initials: MB
authors.lastname: Brown
authors.forename: Mehak
authors.initials: M
authors.lastname: Gupta
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Justice
authors.forename: Besem
authors.initials: B
authors.lastname: Beteck
authors.forename: Mary
authors.initials: M
authors.lastname: Van Demark
authors.forename: Yuan
authors.initials: Y
authors.lastname: Gu
authors.forename: Robert G
authors.initials: RG
authors.lastname: Presson
authors.forename: Walter C
authors.initials: WC
authors.lastname: Hubbard
authors.forename: Irina
authors.initials: I
authors.lastname: Petrache
mesh_terms: D000111:Acetylcysteine / Q000494:pharmacology; D000818:Animals; D061945:Caspase Inhibitors; D020169:Caspases / Q000378:metabolism; D002374:Catalase / Q000494:pharmacology; D002478:Cells, Cultured; D002518:Ceramides / Q000378:metabolism* / Q000494:pharmacology; D003599:Cytoskeleton / Q000378:metabolism; D017097:Electric Impedance; D042783:Endothelial Cells / Q000187:drug effects / Q000378:metabolism; D004727:Endothelium / Q000187:drug effects*; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism; D005260:Female; D006801:Humans; D008168:Lung / Q000473:pathology* / Q000503:physiopathology; D020935:MAP Kinase Signaling System; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D009842:Oligopeptides / Q000494:pharmacology; D016877:Oxidants / Q000494:pharmacology; D018384:Oxidative Stress; D010539:Permeability / Q000187:drug effects; D061251:Primary Cell Culture; D051381:Rats; D017207:Rats, Sprague-Dawley; D012906:Smoke / Q000009:adverse effects*; D012907:Smoking / Q000009:adverse effects*; D014026:Nicotiana / Q000009:adverse effects*
chemical_list: D061945:Caspase Inhibitors; D002518:Ceramides; D009842:Oligopeptides; D016877:Oxidants; D012906:Smoke; C517629:benzyloxycarbonyl-valyl-alanyl-aspartic acid; D002374:Catalase; D020928:Mitogen-Activated Protein Kinases; D020169:Caspases; D000111:Acetylcysteine